Ian Lobley

DiBcom is at the heart of Mobile TV. As a fables semiconductor company that designs high-performance chipsets, DiBcom enables low-power mobile and portable TV reception everywhere and at speeds exceeding 200 km/h. The company's solutions are used in automotive, PC/peripheral, mobile phones and other handheld devices. It has extensive experience solving real-world mobile digital terrestrial television (DTT) reception problems and has overcome the main technological barriers to high-quality service. The company has developed a number of patented algorithms and architectures for fast and accurate channel estimation and high Doppler compensation. Its chipsets are compliant with the current worldwide Digital Video Broadcast standards DVB-T, DVB-H, DVB-SH, T-DMB and ISDB-T.

Nujira Ltd. provides fabless semiconductor devices. It also provides Envelope Tracking technology and solutions for powering 4G cellular terminals, base stations and digital broadcast transmitters. Nujira was founded in 2002 by Tim Haynes and is headquartered in London, the United Kingdom.

The Cloud Networks Ltd. provides Wi-Fi technology. It builds and operates public access on cellular devices, such as smartphones and mobile devices like the iPad, iPod Touch, games consoles, MP3 entertainment devices, laptops or notebooks, Wi-Fi enabled cameras and other mobile Wi-Fi enabled devices. The company was founded by Niall Murphy and George Polk on May 28, 2004 and is headquartered in Middlesex, the United Kingdom.

Psytechnics Ltd. develops voice quality measurement software solutions. It offers a range of active and passive software solutions for both enterprises and service providers markets. The firm’s software solutions are used to improve the performance of real-time communications including unified communications applications and networks designs. The company was founded by Michael Hollier, Phil Gray, Antony W. Rix and Richard J. B. Reynolds in December 2000 and is headquartered in Ipswich, the United Kingdom.

Intense Ltd. designs and manufactures optoelectronic semiconductors. The company is a provider of single and multimode monolithic laser array products and laser diodes. It was founded in 2000 and is headquartered in Glasgow, UK.

Netronome Systems, Inc. designs and supplies flow processing silicon and software for cyber security applications. It offers its products for network analytics, software-defined networking, and cloud data center server virtualization. The firm’s solutions include cloud NFV infrastructure, data center IaaS Applications, openStack cloud networking, network security, data center SDN gateway, and express virtio-XVIO. The company was founded by Niel Viljoen, David Wells, and Johann Tönsing in 2003 and is headquartered in Cranberry Township, PA.

Power Integrations UK Ltd. provides energy-efficient power conversion products. Its applications include mobile, feature, smart phones and media tablets. The company was founded by Gehan Anil Joseph Amaratunga and is headquartered in Cambridge the United Kingdom.

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade.